Chris Gibson, the CEO of Recursion Pharmaceuticals, thinks the future of drug discovery lies within a ChatGPT-like interface. At a J.P. Morgan Healthcare Conference reception co-hosted with Nvidia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback